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Summary 
The effect of the nephrotoxic aminoglycoside antibiotic, 
gentamicin, on calcium uptake by renal cortical mitochondria 
was assessed in vitro. Gentamicin was found to be a competitive 
inhibitor of mitochondrial Ca+' uptake. This effect displayed 
a dose response with a Ki of 233 PM and occurred at gentamicin 
concentrations below those that inhibit mitochondrial electron 
transport. These results further demonstrate the potential for 
gentamicin to alter membrane function and thereby contribute to 
toxic cell injury via its interactions with divalent cations. 
Gentamicin is a polycationic, aminoglycoside antibiotic used frequently 
'for the treatment of serious gram-negative infections. Nephrotoxicity is a 
side effect of this agent, and gentamicin nephrotoxicity is a frequent cause 
of acute renal failure in the clinical setting (1). The biochemical basis of 
renal cell injury in both nephrotoxic and ischemic acute renal failure appears 
to be the disruption of normal membrane function and integrity (2). Altera- 
tions in plasma and mitochondrial membrane structure and function are probably 
critical, and gentamicin provokes substantial derangements in both membrane 
systems early in developing nephrotoxicity (3). 
The mechanisms for the direct in vitro effects of gentamicin at the inner 
mitochondrial membrane have been recently elucidated (42). Due to its cat- 
ionic structure, gentamicin apparentll+competes with Mg at sites on the 
inner mitochondrial membrane where Mg regulates the monovalent cation 
permeability of the membrane. Once occupying these sites, however, gentamicin 
does not limit Na+ and K+ permeability to the same degree as Mg++. Mito- 
chondrial swelling, accelerated State 4 and inhibited State 3 and DNP-uncoupled 
rates result. Since Mg ++ 
Ca++ 
is also an important regulator of mitochondrial 
uptake (6), we undertook the present series of experiments assessing 
the effect of gentamicin on mitochondrial Ca* uptake to further delineate 
the manner in which gentamicin interacts with this important intracellular 
membrane system. 
Methods 
Renal cortical mitochondria were isolated as previously detailed (7). 
Mitochondrial oxygen consumption was measured polarographically at 300C in a 
closed 1.4 ml vessel with stirring bar and thermostatically controlled bath 
(Model K-lC, Gilson Medical Electronics, Inc., Middleton, Wise.). The stan- 
dard incubation medium contained 75 mM KCl, 100 n+l sucrose, 10 mM Tris- 
succinate, 10 mM Tris-HCl, pH 7.4, 1.25 PM rotenone, and 0.75-1.00 mg mito- 
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chondrial protein. For various experiments, concentrated stock solutions of 
gentamicin, MgCl2, or the ionophore, A23187, were added to the incubation 
medium to attain desired concentrations. 
The in i t i a l  rate of mitochondrial calcium uptake as a function of the 
incubation medium free calcium concentration was determined according to the 
method of Reed and Bygrave (8). O.l ml of the concentrated mitochondrial 
suspension (6-8 mg/ml) was added to 0.4 ml of incubation medium so that the 
f inal solution contained 120 mM KCI, 25 mM sucrose, 10 mM Tris-succinate, and 
10 mM Tris-HCl, pH 7.4. Incubations were carried out at 24oc. After 2 min- 
utes preincubation, mitochondrial Ca ++ uptake was ini t iated bv the addition 
of 0.5 ml of an identical solution also containing 1 ~Ci 45Ca$+, 10 mM 
n i t r i l o t r iace t i c  acid (NTA), and varying concentrations of CaCl 2 to attain 
various free Ca ++ concentrations in the medium. The free Ca ++ act iv i ty of 
this f inal incubation solution was measured directly as detailed below. The 
uptake of Ca ++ was terminated after 10 seconds with the addition of 1 ml of 
ice-cold quench solution containing 120 n~MKCI, 10 mM Tris-succinate, 5 mM 
NTA, 6 ~M ruthenium red, 10 mM Tris-ethylene glycol bis-(B-aminoethylether)N, 
N'-tetraacetic acid (EGTA), pH 7.4. 0.5 ml of the quenched mitochondrial 
solution was added to 3 ml of ice-cold rinse solution, containing 120 mM KCI, 
10 mM Tris-HCl, pH 7.4, and f i l te red through 0.5 ~m Mill ipore cellulose 
acetate f i l t e r s  (EHWP). The mitochondria collected on the f i l t e r  were washed 
with an additional 6 ml of rinse solution. The f i l t e r s  were placed in 
sc int i l la t ion vials containing Aquasol (New England Nuclear) and counted in a 
sc int i l la t ion counter. Mitochondrial protein was determined by the method of 
Lowry et al. (9). The in i t i a l  rates of mitochondrial calcium uptake are 
expressed as nmol Ca++/mg mitochondrial protein/lO sec. 
Free Ca ++ act iv i ty in the f inal incubation solution containing 120 mM 
KCI, 5 mM NTA, 10 mM Tris-HCl, pH 7.4 was measured direct ly by a Ca ++ 
selective electrode (Radiometer type F2112Ca) as described by Nichols (10). 
The electrode was calibrated by buffers containing 75 mM KCI, 5 mM potassium 
NTA, 50 mM 2-{[2-hydroxy-l,l-bis(hydroxymethyl)-ethyl]amino}ethanesulphonic 
acid (TES) (potassium salt),  pH 7.0, and various calcium concentrations. For 
calibration, the apparent s tab i l i ty  constant, 8.69x103, was used for NTA at 
pH 7.0 ( i0). 
45CAC12 was obtained from New England Nuclear Corp.; A23187 was a g i f t  
from Dr. Robert Hamill of Eli L i l l y  Co. All other reagents were obtained from 
Sigma Chemical Co. A23187 was dissolved in absolute ethanol and gentamicin 
was prepared as aqueous Tris-gentamicin-SO 4, pH 7.4, in concentrations to 
deliver the required quantity in 10 ~l aliquots. Ruthenium red was used 
without further purif ication. 
Results 
Effect of gentamicin on the A23187-induced rise in mitochondrial respiration . 
In isolated mitochondria, the divalent cation ionophore, A23187, produces 
stimulation of mitochondrial respiration due to persistent, energy-dissipating 
cycling of calcium across the inner mitochondrial membrane (6). The mitochon- 
drial respiratory response to A23187 has, therefore, been used as a sensitive, 
dynamic index of mitochondrial Ca ++ uptake. In this regard, as seen in 
Fig. 1, 2 ~M A23187 produced an increase in mitochondrial oxygen consumption 
from a basal rate of 108+-3 to 186±8, or an average increase of 78±8 nanoatom 
equivalents oxygen/min/mg protein (p <.001). This A23187-mediated increment 
in mitochondrial respiration, however, was progressively and signif icantly 
diminished by 0.1 and 0.5 nW~ gentamicin. Furthermore, the inhibitory effect 
of gentamicin on the respiratory response to A23187 was additive to the 
inhibit ion produced by 0.5 mM Mg ++. 
Vol. 30, No. 26, 1982 Gentamicin and Mitochondr~l Calcium 2311 
8 ~ I00 - D SHAM A23187 
e Q A23187 (2~M) 
E 80 i AZ31S7 (Z M) + w 
~ MgCl 2 (0.5 mM) 
~ - ~  
o 
4 0  
E 20 
Z o ~ c , . .L  
O 0.I 0.5 
GENTAMIClN (raM) 
FIG. 1 
Effects of gentamicin alone and gentamicin + MgCI 2 on the change in 
mitochondrial respiration induced by the calcium ionophore, A23187. Each 
experiment was started by adding mitochondria to the respiratory medium 
detailed under Methods, containing the desired level of Mg ++ and/or 
gentamicin. Mitochondrial Ca ++ levels averaged 30-40 nmol/mg protein. 
After 2 minutes, either A23187 or sham solution (10 pl ethanol) were added 
and the resulting in i t ia l  rate of respiration was measured. 
Effect of 9entamicin on in i t ia l  rate of mitochondrial calcium transport 
Since the respiration experiments only assessed this mitochondrial 
transport process indirect ly, direct measurements were carried out to assess 
the effect of gentamicin on in i t i a l  velocities of mitochondrial Ca ++ uptake 
using 45Ca~ and an EGTA-ruthenium red quench technique (8). The in i t i a l  
rate of mitochondrial calcium uptake as a function of medium Ca ++ concentra- 
tions is sh~n in Figs. 2 and 3. As shown in Fig. 2, at low Ca ~ concentra- 
tions, the relationship is sigmoid rather than hyperbolic. By graphical 
analysis, the K m and Vma x were determined to be 12.0 ~M and 30 nmole/mg 
protein/lO sec, respectively (Fig. 3). As shown in Figs. 2 and 3, gentamicin 
had no effect on Vma x but increased the K m of the Ca ++ uptake process 
from the control value of 12.0 to 13.3, and 60.0 pM for gentamicin concentra- 
tions of .25 and .50 mM, respectively. Analysis by Dixon plot (Fig. 4) 
conf i r~d that gentamicin is a competitive inhibitor of mitochondrial C~ + 
uptake with an approximate K i of 233 pM. Mg ~ also substantially 
inhibited mitochondrial Ca ~ uptake in this system (data not shown) similar 
to the effect observed in the ionophore experiments. However. since Mg ++ 
competes with Ca m for N~ binding and thereby alters free Ca ++ act iv i ty,  
this interaction was not quantitated using the Ca/N~ buffer system. 
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FIG. 2 
Effect of various gentamicin concentrations (e, control; o, 0.025 mM; 
A, 0.25 mM; &, 0.50 mM) on mitochondrial C~ + uptake at low free calcium 
concentrations. 
Discussion 
These data demonstrate that the aminoglycoside antibiotic, gentamicin, is 
a competitive inhibitor of mitochondrial Ca +÷ uptake. This conclusion is 
based upon both indirect and direct measurements. An indirect assessment of 
mitochondrial C~ + uptake was made by measuring the rate of mitochondrial 
respiration after the addition of the divalent cation ionophore A23187. The 
addition of A23187 to an isolated mitochondrial preparation induces release of 
endogenous mitochondrial Ca ++ and energy-dissipating reuptake of Ca ++ via 
the electrophoretic C~ + uniport system (6). The resulting steady state 
recycling of Ca ++ across the mitochondrial inner membrane uncouples oxida- 
tive phosphorylation and increases mitochondrial oxygen consumption. The 
magnitude of the rise in respiration correlates with the rate of Ca ++ uptake 
and is, therefore, sensitive to changes in the mitochondrial C~ + uptake 
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FIG. 3 
Mitochondrial Ca ++ uptake at various medium free Ca ++ concentrations 
in the presence (a) and absence (m) of 0.5 mM gentamicin. 
process. In this regard, the data presented here demonstrated that gentamicin 
signif icant ly decreased the A23187-mediated increase in mitochondrial respira- 
tion, thereby suggesting that gentamicin inhibited mitochondrial Ca ++ uptake. 
This gentamicin effect was dose dependent, since 0.5 mM was more effective 
than 0.1 mM, and was additive to a submaximal concentration of Mg ++, a well 
established competitive inhibitor of mitochondrial Ca ++ uptake (6). 
Direct measurement of Ca ++ uptake also demonstrated that gentamicin 
inhibited mitochondrial Ca ++ uptake. In i t ia l  velocities of mitochondrial 
Ca ++ uptake were assessed with 45Ca++ in a n i t r i l o t r iace t i c  acid (NTA) 
buffer system and with an EGTA-ruthenium red quench technique described by 
Reed and Bygrave (8). NTA is a Ca ++ chelator which effect ively buffers 
++ 6 4 ++ Ca in the important physiologic region of 10- -10- M free Ca . 
The use of an NTAICa ++ buffer system generates stable free Ca ++ 
concentrations, so that substantial mitochondrial uptake of Ca ++ wi l l  not 
perturb the in i t i a l  free Ca ++ concentration even at low free Ca ++ 
concentrations. The quenching of Ca ++ transport with a mixture of the 
high-aff in i ty,  non-competitive inh ib i t ior  of mitochondrial Ca ++ transport, 
ruthenium red, and the high-af f in i ty Ca ++ chelator, EGTA, allows the 
measurement of short, well-defined reaction times while simultaneously 
removing externally bound Ca++. In this experimental system, gentamicin 
increased the K m for the Ca++ transport process in a dose-dependent manner 
without affectinq the Vma x. The K i of this competitive inhibit ion of 
gentamicin on Ca m+ uptake was calculated to be 233 uM by Dixon plot. 
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FIG. 4 
Dixon plot for the inhibition of mitochondrial Ca ++ uptake by 
gentamicin, v o is the in i t ia l  rate of mitochondrial Ca ++ uptake. 
The data also demonstrated that at low free Ca ++ concentrations, the 
relationship between the medium Ca ++ concentration and in i t i a l  velocity of 
the mitochondrial transport process is sigmoid rather than hyperbolic. This 
sigmoidicity has been well described previously in both l iver (11) and kidney 
(12) mitochondria and has been interpreted to ref lect  a positive cooperativity 
between Ca ++ binding sites on the transporter. Since Hi l l  coefficients have 
been reported to be between 1.6-1.7, a minimum of two interacting binding sites 
have been postulated. From our experiments the K m and Vma x of mitochon- 
drial Ca ++ uptake were determined to be 12.0 uM and 30 nmole/mg protein/t0 sec 
respectively, values s l ight ly  lower than those reported by Studer and Borle 
for renal mitochondria (12) and higher than those reported by Reed and Bygrave 
for l iver mitochondria (11). 
The manner in which mitochondria handle Ca ++ is a complex process 
dependent both on uptake and eff lux pathways (13). The uptake transport 
occurs via an electrophoretic uniport system driven by the electrical gradient 
generated across the mitochondrial inner membrane by proton extrusion (14). 
Specific inhibitors of this uptake process have been described and include 
ruthenium red, lanthanum, and magnesium (6,15). These compounds are cationic 
and are capable of binding to negative charges along the membrane. This 
charge interaction appears to be the basis of their inhibitory action on 
mitochondrial Ca++ transport. The binding of Ca++ to i ts carrier is an 
obligatory in i t i a l  step in i ts transport and is due to a charge interaction 
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between Ca ++ and an anionic site ( i i ) .  Interaction with this binding site 
by other cationic substances would effectively inhibit Ca ++ uptake. Since 
gentamicin is a polycation, the mechanism of gentamicin's inhibitory effect on 
mitochondrial Ca ÷+ uptake is most l ikely due to a similar interaction. 
Mitochondrial Ca ++ uptake is primarily electron transport limited (6). 
Gentamicin, however, inhibited mitochondrial Ca ++ uptake at concentrations 
lower than those required to decrease electron transport. In test conditions 
similar to those employed in these Ca ++ transport studies, i .e . ,  in the 
absence of EDTA, gentamicin inhibits State 3 and DNP-uncoupled respiration 
only at concentrations greater than 1 mM (4). In contrast, gentamicin concen- 
trations as low as .025 mM inhibited mitochondrial Ca ++ uptake. The inhib- 
itory effect of gentamicin on this transport process, therefore, appears to be 
independent of i ts effect on mitochondrial electron transport. The present 
paper adds to a growing body of data demonstrating the potential for gen- 
tamicin to interact with divalent cations on subcellular membranes of the 
renal tubular epithelial cell and thereby influence important functional 
properties whose derangement may contribute to i ts nephrotoxicity. 
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